Lataz (Latanoprost)

Latanoprost activates prostaglandin F (FP) receptors in the eye, increasing uveoscleral outflow of aqueous humor. This enhanced drainage reduces intra‑ocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Lataz is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but exact instructions must follow the prescriber’s order.

The safety of latanoprost in pregnancy or while breastfeeding has not been established. Physicians should weigh potential benefits against unknown risks and consider alternative treatments when appropriate.

To order Lataz, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lataz (latanoprost) is a prostaglandin analog, generally offering once‑daily dosing and strong intra‑ocular pressure reduction. Compared with beta‑blocker drops, it often provides greater efficacy with fewer systemic side effects, though individual response may vary.

Lataz should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and discard any solution that appears discolored or contaminated.

Lataz is applied as an ophthalmic solution. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place one drop into the conjunctival sac of the prescribed eye(s) without touching the tip to the eye or lashes.

Serious risks, though rare, include severe allergic reactions, uveitis or intra‑ocular inflammation, and a paradoxical increase in intra‑ocular pressure. Any sudden eye pain, redness, or vision changes should prompt immediate medical evaluation.

Lataz should be avoided in patients with known hypersensitivity to latanoprost or any component of the formulation, active ocular infections, or those who have experienced a paradoxical pressure rise with prostaglandin analogs. Pediatric use requires specific medical guidance.